China Pharma Inc.

AMEX: CPHI · Real-Time Price · USD
1.46
0.00 (0.00%)
At close: Aug 15, 2025, 9:59 AM

China Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-4.74M -3.08M -3.97M -3.4M
Depreciation & Amortization
2.62M 2.75M 2.7M 3.09M
Stock-Based Compensation
n/a n/a 78.27K 15.24K
Other Working Capital
520.23K 246.86K 547.17K -520.41K
Other Non-Cash Items
456.44K 21.65K -93.85K 250K
Deferred Income Tax
n/a n/a n/a -255.22K
Change in Working Capital
1.2M -396.18K 878.34K 51.79K
Operating Cash Flow
-466.36K -699.69K -409.55K -249.84K
Capital Expenditures
-291.72K -11.52K -401.96K -438.06K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-253.31K n/a n/a n/a
Investing Cash Flow
-291.72K -11.52K -401.96K -438.06K
Debt Repayment
27.35K 73.14K -1.55M 4.6M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -223.01K n/a
Financial Cash Flow
27.35K 73.14K -1.77M 4.6M
Net Cash Flow
-796.96K -606.13K -2.83M 3.9M
Free Cash Flow
-758.08K -711.2K -811.51K -687.89K